Company intelligence / Profile preview
Myrio Therapeutics
Melbourne, Victoria, Australiamyriotx.com ↗
- Ownership
- Private
- Employees
- ~11-50
- Development stage
- Preclinical
01
Overview
No active clinical trials found on ClinicalTrials.gov. The company is focused on antibody discovery against difficult targets like peptide-MHC complexes.
- Therapeutic areas
- Oncology
- Modalities
- Antibody-based therapiesscFv fragmentsBispecific antibodiesCAR-T
- Industry
- Biotech
02
Drug pipeline
22 assets21 more assets in the full pipeline.
Request access →03
Partnerships
Collaborating with leading institutions on targets including endogenous retroviruses and patient-specific neoantigens
Beyond the preview
Go deeper on Myrio Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myrio Therapeutics.